Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
about
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFßCellular traction stresses increase with increasing metastatic potentialClioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.Nest expansion assay: a cancer systems biology approach to in vitro invasion measurementsReal-time motion analysis reveals cell directionality as an indicator of breast cancer progressionStructure–function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097Nek2 activation of Kif24 ensures cilium disassembly during the cell cycleThe Polycomb group protein EZH2 impairs DNA repair in breast epithelial cellsOncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptorCell type-specific activation of AKT and ERK signaling pathways by small negatively-charged magnetic nanoparticlesEssential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cellsProteome-wide profiling of the MCF10AT breast cancer progression modelIntegrated proteomic and metabolic analysis of breast cancer progressionMultiphoton spectral analysis of benzo[a]pyrene uptake and metabolism in breast epithelial cell linesRegulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.Chromosomal gain promotes formation of a steep RanGTP gradient that drives mitosis in aneuploid cells.Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence.Imaging and quantifying the dynamics of tumor-associated proteolysis.Adhesion rings surround invadopodia and promote maturation.miR-200-containing extracellular vesicles promote breast cancer cell metastasis.Comprehensive analysis of proteins of pH fractionated samples using monolithic LC/MS/MS, intact MW measurement and MALDI-QIT-TOF MSClassification of cancer cell lines using an automated two-dimensional liquid mapping method with hierarchical clustering techniques.Smad4-expression is decreased in breast cancer tissues: a retrospective study.Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition.Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesisDynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell linesCytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines.Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.Stem cells in the human breastAn integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancerMetabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells.Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progressionRole of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumorsDNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype.ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.Selective mitogen activated protein kinase activity sensors through the application of directionally programmable D domain motifs
P2860
Q54904297-3F21E36B-96D8-48CA-8CFC-7DAC05794023Q54904434-837FD616-E429-40A8-A680-C853A668B156Q54904438-5BDB4380-8AFE-4C2D-8C04-D0FF0DFD0BDEQ54904439-220C0CA8-EB59-4D7D-BC39-1188253CE46FQ54904441-E272BA64-48F9-4F37-96CF-895015C39968Q54904442-CF94E602-88B9-4630-BE63-8295B5787D7EQ54904443-1A29978E-BBCC-4095-86E3-687ECF497786Q54904444-3A6DE56E-885D-4896-A90B-46EC20F0A28CQ54904445-D6F928D3-F63D-44B5-BBC3-77EF13F7B4DCQ54904446-98672AF0-8231-45EA-86CE-4E7A3AB4EC4EQ95986693-E13EC55D-1211-46E5-8C01-CB8E9A0C850C
P1343
Q21133567-4E3D3C18-2371-40ED-8B1B-92DB93AED23FQ21134747-DF92ECF9-329B-4BED-AA0A-EF43A376E23AQ21195237-BA2480A2-297F-4230-BC45-544C50A89F11Q21202154-A6C242CE-81E6-472B-9F7E-9F774F621046Q27334635-7E93D04D-6696-4619-B44A-2C4DA5051C38Q27676305-AD41A89D-4050-407A-B520-2B9F1AA2175AQ28118308-A98CA9ED-F6F0-4A30-B088-2AA3D892FAD9Q28285316-81124D2F-AD65-4F87-8069-465C6951BBF9Q28304891-6FC3FA06-3BBF-4281-B12B-8A68E90BBAC2Q28391111-8BCB95F2-1E79-45CA-810F-FFB8061162A0Q28473926-65024108-BD4D-451C-8FD9-B5B02CE24EB9Q28474333-89DE417D-3772-426E-9401-53F8351785E8Q28533861-7B1B54A5-5C4A-4217-BD24-69109A5D06BBQ28751699-F28C1612-0730-4F85-8D5B-9DFE720467B8Q30353099-DA06CAC7-A994-44C8-BC83-B71C98C9726FQ30418144-AE23A0A4-DD5A-46ED-B203-6EEF3B74B79DQ30427356-140E23C1-9D6F-403D-8C29-6B90D9C4E38DQ30483094-25636D67-CFB4-41D4-B4FF-E60E68FA79FFQ30497465-257EA107-537D-4560-B9D1-29C7EA6DC393Q30528643-98F62216-6E18-4411-98E0-D84076A64420Q30624403-EC1B0AFD-AAA0-4F14-89A3-919B71E357CAQ30828985-D8337849-16FF-4F91-A637-5BB59449F960Q33222790-3BF9DF38-FCB2-4775-AF6A-798AC58AE38EQ33232550-18AEC048-FD07-455B-969F-4AA4C853DAADQ33532630-C79F94CF-AB08-47B7-88B5-4BA9E54F83B6Q33553472-51BB3324-BED3-4A90-A24C-43E60BE73AFCQ33566597-7874791C-80A0-4FD2-A26D-AAFE668414C6Q33584289-8FD5A843-1791-431A-8D1E-52DD1A5F6DFFQ33627158-48E75B92-F66E-4DC9-9D49-F1FF1BEC8D19Q33677510-FE7E1877-96B4-43A3-BCAE-96B11B1773EAQ33705060-A41C823D-7268-41CA-BC9E-19C78D0DD9BDQ33800311-3B8F1F7B-3A3F-4F03-B454-BA9BDBDCAAD1Q33892460-E81FB947-F951-40E5-8CAC-5664B49CA126Q33993449-4AA175DE-AD95-462C-BBDC-069460098D96Q34005315-DFAD2295-BF7F-4736-9B00-C8E7661E8BF8Q34010802-610B7E00-16E9-414B-9E24-81264A5C024AQ34027977-027505F7-F8F2-4024-8CD3-2F0B979F2199Q34042660-08EBCECC-307E-4689-9A2E-F7D7D5C900D9Q34182938-2B429CA8-A57C-4D0C-9B45-835AEB647A47Q34193885-3FD31B4A-B4CA-4F34-9312-4F6F080571CE
P2860
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@en
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@nl
type
label
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@en
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@nl
prefLabel
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@en
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@nl
P2093
P4510
P356
P1476
Malignant MCF10CA1 cell lines ...... east epithelial MCF10AT cells.
@en
P2093
Heppner GH
Mohamed AN
Santner SJ
P2888
P304
P356
10.1023/A:1006461422273
P407
P4510
P577
2001-01-01T00:00:00Z
P6179
1001709147